Pregnancy is one of the most significant journeys a family undertakes — and prenatal genetic testing has transformed what expecting parents can know about their baby's health before birth. From screening for chromosomal conditions to identifying inherited genetic disorders, these tests offer information that can guide medical care, family planning decisions, and emotional preparation.
What Is Prenatal Genetic Testing?
Prenatal genetic testing encompasses a range of tests performed during pregnancy to assess the risk of or diagnose genetic conditions in the developing baby. Tests fall into two broad categories: screening tests (which assess risk) and diagnostic tests (which confirm or rule out a diagnosis).
Key Types of Prenatal Genetic Tests
Non-Invasive Prenatal Testing (NIPT)
NIPT analyzes cell-free fetal DNA circulating in the mother's blood from as early as 10 weeks of pregnancy. It screens for the most common chromosomal conditions with high accuracy:
- Trisomy 21 (Down syndrome) — >99% sensitivity
- Trisomy 18 (Edwards syndrome)
- Trisomy 13 (Patau syndrome)
- Sex chromosome abnormalities
- Microdeletion syndromes (in expanded panels)
NIPT is non-invasive — it requires only a maternal blood draw and carries no risk to the pregnancy.
First-Trimester Combined Screening
Combines nuchal translucency ultrasound (measuring fluid at the back of the baby's neck) with blood tests measuring PAPP-A and free beta-hCG. Performed between 11–14 weeks. Provides a risk estimate for Down syndrome and other chromosomal conditions.
Second-Trimester Quad Screen
A blood test measuring four markers (AFP, hCG, estriol, inhibin A) to assess risk for Down syndrome, Trisomy 18, and neural tube defects. Performed between 15–20 weeks.
Carrier Screening
Tests both parents for carrier status for inherited recessive conditions — including thalassemia, sickle cell anaemia, cystic fibrosis, and spinal muscular atrophy. If both parents are carriers of the same condition, each pregnancy has a 25% chance of being affected.
Diagnostic Tests (Amniocentesis and CVS)
Amniocentesis (15–20 weeks) and chorionic villus sampling (CVS, 10–13 weeks) provide definitive chromosomal diagnoses. They carry a small procedural risk and are typically recommended when screening results indicate elevated risk.
Benefits of Prenatal Genetic Testing
- Early information: Allows parents to prepare emotionally, medically, and practically for a child with special needs.
- Informed decision-making: Guides decisions about further testing, delivery planning, and specialist consultations.
- Reassurance: For most parents, results are normal — providing significant peace of mind.
- Medical preparation: Certain conditions benefit from delivery at a specialist centre or immediate neonatal intervention.
FAQs
Is prenatal genetic testing mandatory?
No. Prenatal genetic testing is always optional. The decision to test is personal and should be made after discussion with your obstetrician and, ideally, a genetic counsellor.
What happens if a test result is abnormal?
An abnormal screening result does not mean your baby definitely has a condition — it means the risk is elevated and further diagnostic testing is recommended. A genetic counsellor can help you understand your results and options.
India’s Most Accurate Non-Invasive Prenatal Test
MapmyGenome's BabyMap NIPT screens for chromosomal abnormalities including Down syndrome, Edwards syndrome, and Patau syndrome from as early as 10 weeks — with no risk to your pregnancy. Backed by NABL-certified labs and expert genetic counsellors.
